Catechol-O-methyltransferase gene variants may associate with negative symptom response and plasma concentrations of prolactin in schizophrenia after amisulpride treatment-Reference-Cited by-同舟云学术

Catechol-O-methyltransferase gene variants may associate with negative symptom response and plasma concentrations of prolactin in schizophrenia after amisulpride treatment

Published:2016-03 Issue: Volume:65 Page:67-75
ISSN:0306-4530
Container-title:Psychoneuroendocrinology
language:en
Short-container-title:Psychoneuroendocrinology

Author:

Chen Chun-Yen,Yeh Yi-Wei,Kuo Shin-Chang,Ho Pei-Shen,Liang Chih-Sung,Yen Che-Hung,Lu Ru-Band,Huang San-Yuan

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health,Endocrine and Autonomic Systems,Endocrinology,Endocrinology, Diabetes and Metabolism

Reference40 articles.

1. Diagnostic and statistical manual of mental disorders;American Psychiatric Association,2000

2. Haploview: analysis and visualization of LD and haplotype maps;Barrett;Bioinformatics,2005

3. COMT Val158Met polymorphism predicts negative symptoms response to treatment with olanzapine in schizophrenia;Bertolino;Schizophr. Res.,2007

4. Factors affecting cognitive remediation response in schizophrenia: the role of COMT gene and antipsychotic treatment;Bosia;Psychiatry Res.,2014

5. Is regionally selective D2/D3 dopamine occupancy sufficient for a typical antipsychotic effect? an in vivo quantitative [123I] epidepride SPET study of amisulpride-treated patients;Bressan;Am. J. Psychiatry,2003

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COMT and Neuregulin 1 Markers for Personalized Treatment of Schizophrenia Spectrum Disorders Treated with Risperidone Monotherapy;Biomolecules;2024-06-29

2. The effects of catechol‐O‐methyltransferase single nucleotide polymorphisms on positive and negative symptoms of schizophrenia: A systematic review and meta‐analysis;PsyCh Journal;2022-05-31

3. Association Between the COMT Val158Met Polymorphism and Antipsychotic Efficacy in Schizophrenia: An Updated Meta-Analysis;Current Neuropharmacology;2021-10-18

4. Applying Pharmacogenomics in Drug Therapy of Neurologic and Psychiatric Disorders;Reference Module in Biomedical Sciences;2021

5. Genetic Markers for Later Remission in Response to Early Improvement of Antidepressants;International Journal of Molecular Sciences;2020-07-10